Navigation Links
Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
Date:10/30/2008

Palo Alto, CA and New York, NY, October 30, 2008 Bayhill Therapeutics, Inc., a leading developer of therapies for autoimmune diseases, and the Juvenile Diabetes Research Foundation, the world's leading charitable funder of type 1 diabetes research, today announced a partnership to support Bayhill's ongoing Phase I/II human clinical trial of BHT-3021, a DNA vaccine to reverse the immune response that causes type 1 diabetes.

BHT-3021 is an antigen-specific immunotherapeutic DNA vaccine designed to reverse the underlying autoimmune disease process in diabetes, and slow down or halt further loss of pancreatic beta cell function.

"We are very pleased to have the support of JDRF as we advance the clinical development of BHT-3021," said Mark W. Schwartz, Ph.D., Bayhill's President and CEO. "This agreement demonstrates JDRF's commitment to funding ground-breaking clinical research and to the development of novel therapeutics that can potentially have an important impact on the lives of people with diabetes. There are currently no disease-modifying products available to the millions of patients suffering from this disease. We believe BHT-3021 will provide a better treatment alternative for them."

JDRF funds diabetes research across a range of scientific areas, including beta cell regeneration, immunology, islet cell replacement, complications, genetics, and technological innovations and therapeutics to improve metabolic control. The agreement with Bayhill is a part of JDRF's innovative Industry Discovery and Development Partnership program, through which JDRF partners with pharmaceutical, biotech, and medical device businesses looking to develop drugs, treatments, technologies, and other therapeutics leading to a cure, reversal, or prevention of type 1 diabetes and its complications. Through its IDDP Program, JDRF will provide up to $3 million toward the Phase I/II clinical trial. Funding will be based on Bayhill attaining specific clinica
'/>"/>

Contact: Leslie Schwartz
lschwartz@jdrf.org
212-479-7553
Juvenile Diabetes Research Foundation International
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
2. Michael J. Fox Foundation PD Therapeutics Conference
3. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
4. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
5. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
6. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
7. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
8. Gender, coupled with diabetes, affects vascular disease development
9. Breakthrough research identifies how cells from pigs may cure diabetes
10. Botched production of insulin molecule may lead to diabetes
11. Joslin researchers uncover potential role of leptin in diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , In the current online issue of the Journ...h and Dr. Kilian Eyerich together with their colle...rmopatico dell,Immacolata in Rome, present their g... on the way to developing new treatment methods fo... allergic reactions and potentially also allergic ...
(Date:11/20/2009)...ter (ERC) has been awarded a grant from the U.S. D...covering and reusing the heat that would be genera...ess in a carbon capture system. The goal of the re... sequestration, or storage (CCS), and thus limit t... the atmosphere by coal-fired power plants. , Un...
(Date:11/19/2009)...he end of the last ice age, North America,s vast a...creatures as mammoths, mastodons, camels, horses, ...pitous slide to extinction. , And when their pop...of large animals equaled or surpassed Africa,s wil...ly novel ecosystem emerged as broadleaved trees on...
Breaking Biology News(10 mins):Discovery of new type of immune cells regulating inflammation in chronic diseases 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Highest ever winter water temperatures recorded 9516 1Highest ever winter water temperatures recorded 9516 2Photo 3A New Survey Results Show Most Moms Are Aware Their Pre teens and Teens Need Vaccines 53947 1Photo 3A New Survey Results Show Most Moms Are Aware Their Pre teens and Teens Need Vaccines 53947 2Photo 3A New Survey Results Show Most Moms Are Aware Their Pre teens and Teens Need Vaccines 53947 3ConvaTec Launches Versiva 28R 29 XC 28R 29 Campaign and Best Practice Statement 53943 1ConvaTec Launches Versiva 28R 29 XC 28R 29 Campaign and Best Practice Statement 53943 2ConvaTec Launches Versiva 28R 29 XC 28R 29 Campaign and Best Practice Statement 53943 3ConvaTec Launches Versiva 28R 29 XC 28R 29 Campaign and Best Practice Statement 53943 4ConvaTec Launches Versiva 28R 29 XC 28R 29 Campaign and Best Practice Statement 53943 5
...n,s disease (HD) is caused by a mutant protein tha...ring the genetic neurological disorder. Now a new ...first strong evidence that the mutant protein also... to provoke the fatal brain disorder. The May 5 ed...eally important because most current disease model...
...n from North America to Mexico, monarch butterflie... as a celestial guide to help them keep to a strai...navigational machinery have remained a mystery. , ...ity of Massachusetts Medical School, Ivo Sauman of... of the University of California at Irvine, have e...
...irginia Tech have enhanced the abilities of the mo... to cancer cells. The man-made molecular complexes...lling medicine or cause the cell to change. The ne...light - providing more control over the range of l... as signals and the responses. , Karen Brewer, pro...
Other Biology News:New insights into how Huntington's disease attacks the brain 2How monarch butterflies are wired for navigation 2Bad aftertaste? New sensory on/off switch may 'cure' bane of artificial sweetener search 2Bad aftertaste? New sensory on/off switch may 'cure' bane of artificial sweetener search 3
(Date:11/19/2009)...ire/ -- Dr. Mate Hidvegi, inventor of Avemar ferme...se issued on November 17 by Biropharma Kft, discre...self-serving statements about its U.S. competitor ...om his office in Budapest, Hungary: ,, "The Bi...ply to AveULTRA, www.aveultra.com , is misleadi...
(Date:11/19/2009)...rstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), anno...to its shareholders, discussing the Company,s acqu...uticals Holdings, Inc. (CHBP), an integrated bio-p...ic of China. The merger gives NeoStem a controllin...td., CHBP,s primary operating subsidiary and a pro...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)... Aegera Therapeutics Inc. announced today the dosi...tudy of AEG35156, a targeted antisense therapeutic...dications. ,, The study, entitled "An Open-Labe...or of Apoptosis (XIAP) Antisense AEG35156 Given in...cin in AML Following Failure of a Single Standard ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...Business Filings Incorporated, an online firm with...cross the board to BizFilings after finding that t... company helps form corporations, limited liabilit...he shorter name of BizFilings with most of our web...to businessfilings.com, said Mark Schiff, the firm...
Computer access brings more Wisconsinites to libraries
... could have a regional economic development corpor...e Collaboration Council, a group of local business...f support that crosses the boundaries between muni...ane County as a whole as a competitor in the globa... , ,Dane County has grown by more than 30,000 peop...
Other Biology Technology:Local group building Dane County economic development corp. 2
...&D Systems adds two new Stem Cell Antibody Panels ...uman Embryonic Stem Cell Marker Antibody Panel (Ca...kaline phosphatase, Nanog, Oct-3/4, SSEA-1 and SSE... Panel Plus (Catalog # SC009) contains antibodies ...
Anti-Epstein-Barr Virus (EBV) (EBNA-1) Polyclonal Antibody, Biotin Conjugated from ViroStat Inc.
Rabbit Anti-ECE-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems
Biology Products: